Navigation Links
Low-cost molecular medicine should be included in modern eye physicians' tool kit
Date:4/16/2011

Dr. Richer, speaking at his 4th annual Nutrition & The Eye conference, April 16-17, hosted by the College of Optometry at the University of Missouri in St. Louis, says molecular medicine is beginning to provide hope for patients with declining sight when all other therapies have been exhausted. "These nutritional molecules have begun to be rigorously studied around the world in cardiology , cancer research and some human studies", Dr Richer reported.

Dr. Richer has now accumulated a growing number of otherwise hopeless cases that retina specialists and other ophthalmologists referred to his center. These low-cost preventive molecular medicine approaches have worked without fail so far, he says. Dr. Richer presented six separate cases where molecular medicine sometimes improved functional vision within days, which was unexpected.

A recent case, says Dr. Richer, is an 88-year old woman with macular degeneration, an age-related eye disorder that robs seniors of their central vision.[ NOT TRUE REFUSED TX--whom retinal specialists said was beyond any help offered by conventional medicines and surgeryjust omit]. Employing a molecular medicine regimen, this hospitalized woman regained her ability to see faces, read a menu and visualize her handwriting in just four days. Her vision improvement was in both eyes says Dr. Richer. "A second 88-year old patient, this time with "dry" macular degeneration, took 10 weeks to see clinical improvement, but by 20 weeks the retina appeared to return to a more youthful appearance with 20/20 vision."

Dr. Richer says, typically in the cases he has monitored, blind spots (called scotomas) disappear, time to recover from bright light (glare recovery test) is reduced, and contrast vision (shades of grey) as well as visual acuity (ability to see letters on a chart) generally improve within 3-6 weeks on a molecular medicine regimen that provides small molecules that bind to (chelate) to minerals such
'/>"/>

Contact: Stuart Richer O.D., Ph.D.
stuartricher1@comcast.net
847-409-4131
Resveratrol Partners LLC, dba LONGEVINEX
Source:Eurekalert

Page: 1 2

Related biology news :

1. New lab-on-chip advance uses low-cost, disposable paper strips
2. New low-cost method to deliver vaccine shows promise
3. Undergraduates low-cost ultrasound system wins Gates Foundation grant
4. Low-cost, ultra-fast DNA sequencing brings diagnostic use closer
5. Simple, low-cost steps enhance adolescents health
6. Covering the bases: Quantum effect may hold promise for low-cost DNA sequencing, sensor applications
7. Pilot study shows effectiveness of new, low-cost method for monitoring hand hygiene compliance
8. Cellulosic biofuel technology will generate low-cost green fuel, says major study
9. High Performance, Low-Cost VoIP Chips Address Critical Performance Issues Such as Echo, Latency, and Packet Loss
10. Molecular messages from the antennae
11. Chemical engineers at UCSB design molecular probe to study disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2015)... WALTHAM, Mass., Feb. 10, 2015  Alere Inc. ... announced its financial results for the quarter ended ... Executive Officer and President of Alere said, "We ... refocussing Alere as the global leader in rapid ... closing the Alere Health divestiture in early January ...
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... corporate website ( http://www.nxt-id.com/ ) as part of its ... wallet. The Company launched its new consumer website for ... Pereira , CEO of NXT-ID said, "Our new corporate ...
(Date:2/5/2015)... , Jan. 30, 2015  It is gratifying to ... and potential for genomic science as a means to ... prevention and treatment.  I was honored to participate in ... precision medicine program. Since the 1980s ... of genomics—from the first sequenced genome of a free ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
... DCResearchers at the Center for Neuroscience Research ... two major types of signaling pathways activated during brain ... Notch pathwayoperate together to determine how many and which ... repair in developing and adult brains. This knowledge may ...
... Cancer Epidemiology (LACE) study, 1,897 participants diagnosed with early-stage ... average 2 years post-breast cancer diagnosis were evaluated for ... and death. The women, who were generally light ... The study reported an increase in risk of ...
... there,s a new reason to grab a glass of milk when ... American Journal of Clinical Nutrition . In a 2-year weight loss ... milk. Israeli researchers found that adults who drank the most milk ... levels at 6 months, lost more weight after 2 years than ...
Cached Biology News:Discovery of key pathway interaction may lead to therapies that aid brain growth and repair 2New study finds milk drinkers may have a healthy weight advantage 2
(Date:3/6/2015)... 06, 2015 Global Specimen Solutions, ... focused on specimen management and informatics, announced today ... Specimen Solutions, Inc. is excited to catapult our ... that will further enhance our proprietary informatics tools ... specimen research. GSS has proved rapid market uptake ...
(Date:3/6/2015)... 6, 2015   Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... that John Poyhonen , the Company,s President and ... Vice President and Chief Financial Officer, will present an ... Wednesday, March 11, at 2:00 p.m. Eastern Time (11:00 ...
(Date:3/6/2015)... 2015 Anton Paar has released an ... utilizing laboratory refractometers. Sodium hydroxide (NaOH, also known ... a variety of products including pretzels, colored fabrics, soap ... of the chemical industry; its applications range from the ... everything in between. NaOH is used in the ...
(Date:3/6/2015)... Die SARAH-Studie ... Assistance Publique - Hôpitaux de ... französische, gemeinschaftliche, randomisierte Kontrollstudie für die mehr ... werden Patienten mit fortgeschrittenem hepatozellulärem Karzinom (HCC), ... behandelt wurden. Die Ergebnisse werden für Ende ...
Breaking Biology Technology:Global Specimen Solutions, Inc. Closes Series A Funding 2Global Specimen Solutions, Inc. Closes Series A Funding 3SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE THE 27TH ANNUAL ROTH CONFERENCE 2Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 2Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 3Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 4Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 5Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 6
... 2009) will feature OpenClinica in a special workshop titled "Open Source ... ... Porto, Portugal (PRWEB) January 8, 2009 -- OpenClinica will be ... Health Informatics (HEALTHINF 2009) January 14-17, 2009 in Porto, Portugal. The ...
... January 7, 2008 Researchers from Harvard University and ... first time, a repulsive quantum mechanical force that could be ... applications. , The study, led by Federico Capasso, Robert L. ... and Applied Science (SEAS), will be published as the January ...
... 7 Amgen (Nasdaq: AMGN ) will present ... 9:00 a.m. Pacific Time on Monday, Jan. 12, 2009, at ... Chairman and CEO Kevin Sharer will present at the conference. ... Internet and can be accessed from Amgen,s Web site, ...
Cached Biology Technology:OpenClinica to Present at International Conference on Health Informatics, January 14-17, Porto, Portugal 2Researchers measure elusive repulsive force from quantum fluctuations 2
... >95%NEN Radiolabeled Ligands\n\nReceptor-related research has long been ... radiolabeled ligands selected to keep pace with ... of products and services for receptor research ... radioligands. If you do not find exactly ...
... Fluorescence Test Plate consists of an anodized ... Inert Organic Fluorescent Compounds embedded in polymerized ... on BioTeks FLx800 and Synergy Multi-Detection Readers. ... GLP compliance while reducing the need for ...
... Software reads and processes raw ... microarray data for analysis. ... one 2-year license for Feature ... , * one CD-ROM ...
... Gel Stain combo offers these benefits: ... separately Offers a safer ... Eliminates risks to yourself, the environment and ... 100 bp to >30 kb. UltraPure Agarose is a ...
Biology Products: